NRX Pharmaceuticals Inc

XNAS:NRXP

1.85

+0.01 (+0.54%)

7:49:53 PM EDT: $1.81 -0.04 (-2.10%)

Market Cap (Intraday)	58.96M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	2.68

See more stats

Estimates Current Quarter

Revenue	$7.53 Million
Adjusted EPS	$0.01

See more estimates

10-Day MA	$1.87
50-Day MA	$1.96
200-Day MA	$2.62

See more pivots

NRX Pharmaceuticals Inc Stock, XNAS:NRXP

1201 Orange Street, Suite 600, Wilmington, Delaware 19801

United States of America

Phone: +1.484.254.6134

Number of Employees:

http://www.nrxpharma.com

Description

NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered in Wilmington, DE.